Effects of Patient Navigation, Lower-Cost Drug Alternatives on the Cost of Cancer Care and Rates of Metastatic Cancer Diagnoses and Deaths After Medicaid Expansion: Research from the 2022 ASCO Quality Care Symposium
Read research from the 2022 ASCO Quality Care Symposium, including studies on how cancer navigation programs and lower-cost drug alternatives can lower the cost of care and a study on how Medicaid expansion affected the rates of metastatic cancer diagnoses and cancer deaths.